1. Victoza, an injection, is approved to treat Type 2 diabetes in pediatric patients. It had previously been approved to treat adult diabetes patients.
2. The FDA approved a supplemental drug application for Dextenza. It is now approved to treatment ocular inflammation after eye surgery.
3. Allergan received expanded approval for Botox. It is now approved for the treatment of pediatric patients with upper limb spasticity.
4. Keytruda won a label expansion after the FDA approved the drug for patients with metastatic small lung cancer with disease progression on or after chemotherapy and another prior line of therapy.
More articles on pharmacy:
Lupin recalls 18,408 bottles of antibiotic in US
Bluebird Bio prices gene therapy at $1.8M
10 hospitals seeking pharmacy leaders
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
